Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#61 / 200 Total
NKGN - NKGen Biotech Inc - Stock Price Chart
TickerNKGN [NASD]
CompanyNKGen Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap36.87MEPS (ttm)-4.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1486.44%
Dividend-Sales Q/Q-
Insider Own58.03%Inst Own8.08%
Insider Trans0.01%Inst Trans14.32%
Short Float5.83%Earnings-
Analyst Recom-Target Price-
Avg Volume4.15M52W Range0.78 - 12.88
May-21-24 09:53AM NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024 (InvestorPlace)
May-20-24 11:41AM NKGN Stock Alert: The Alzheimer's News That Has NKGen Biotech Soaring Today (InvestorPlace) +52.68%
08:05AM NKGen Biotech's SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer's Disease (GlobeNewswire)
May-16-24 08:05AM NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition (GlobeNewswire)
Apr-29-24 08:00AM NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinsons Disease (GlobeNewswire)
Apr-25-24 04:05PM NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) +15.79%
Apr-24-24 04:45PM NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -7.57%
Apr-18-24 04:05PM NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) -16.50%
Apr-16-24 11:53PM NKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 08:05AM NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs (GlobeNewswire)
BE - Bloom Energy Corp - Stock Price Chart
TickerBE [NYSE, RUT]
CompanyBloom Energy Corp
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap3.88BEPS (ttm)-1.36
P/E-EPS this Y246.45%
Forward P/E35.08EPS next Y232.42%
PEG-EPS past 5Y22.66%
P/S3.00EPS next 5Y-
P/B8.32EPS Q/Q26.34%
Dividend-Sales Q/Q-14.50%
Insider Own15.00%Inst Own75.96%
Insider Trans-0.44%Inst Trans11.46%
Short Float20.99%EarningsMay 09/a
Analyst Recom2.12Target Price16.36
Avg Volume5.82M52W Range8.41 - 18.76
Today 06:30AM Beyond Nvidia: 3 Under-the-Radar Stocks to Cash In on the AI Boom (Motley Fool) +12.89%
May-21-24 03:13PM Why Bloom Energy Surged Today (Motley Fool) +17.11%
11:30AM 3 Hydrogen Stocks to Buy Now: May 2024 (InvestorPlace)
May-20-24 06:20PM 3 Hydrogen Stocks to Buy on the Dip: May 2024 (InvestorPlace)
02:25PM 3 Cheap Hydrogen Stocks to Buy Now: May 2024 (InvestorPlace)
May-17-24 02:34PM 12 Stocks to Play Growing Energy Demand, From Oil and Gas to Nuclear and Solar (Barrons.com)
May-15-24 06:45PM Analyst Report: Bloom Energy Corporation (Morningstar Research)
May-14-24 03:31PM Why FuelCell Energy, Bloom, and Clean Energy Fuels Rose Today (Motley Fool) +8.05%
09:00AM C3 AI and Bloom Energy Team Up to Revolutionize Fuel Cell Performance, Service, and Engineering Analytics (Business Wire)
May-13-24 08:13PM Wall Street Favorites: 3 Hydrogen Stocks With Strong Buy Ratings for May 2024 (InvestorPlace)
GCT - GigaCloud Technology Inc - Stock Price Chart
TickerGCT [NASD]
CompanyGigaCloud Technology Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap1.15BEPS (ttm)2.58
P/E10.95EPS this Y32.39%
Forward P/E7.34EPS next Y26.11%
PEG-EPS past 5Y208.72%
P/S1.39EPS next 5Y-
P/B3.62EPS Q/Q69.63%
Dividend-Sales Q/Q96.47%
Insider Own52.84%Inst Own15.41%
Insider Trans-10.21%Inst Trans324.24%
Short Float17.12%EarningsMay 09/b
Analyst Recom1.00Target Price52.33
Avg Volume3.02M52W Range5.30 - 45.18
TodayInitiated Maxim Group Buy $69
Today 09:46AM Grizzly Research Releases Coverage Report on GigaCloud (NASDAQ:GCT) (News Direct) -10.37%
May-21-24 07:53AM GigaCloud Technology Insider Sold Shares Worth $523,325, According to a Recent SEC Filing (MT Newswires)
May-20-24 03:02PM Invest in the Underestimated: 7 Bargain Stocks Poised to Prove Wall Street Wrong (InvestorPlace) -8.70%
May-18-24 09:00AM 7 Great Growth Stocks You Need to Own Before 2025 (InvestorPlace)
May-17-24 03:10AM GigaCloud Technology Insider Sold Shares Worth $8,642,163, According to a Recent SEC Filing (MT Newswires)
May-16-24 03:06AM GigaCloud Technology Insider Sold Shares Worth $1,033,917, According to a Recent SEC Filing (MT Newswires)
May-15-24 08:00AM 3 Stocks That Can Turn $1,000 into $10,000 Faster Than You Think (InvestorPlace) -5.71%
03:10AM GigaCloud Technology Insider Sold Shares Worth $12,700,553, According to a Recent SEC Filing (MT Newswires)
May-14-24 09:00AM GigaCloud Technology Inc. (GCT) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
03:21AM GigaCloud Technology Insider Sold Shares Worth $9,029,704, According to a Recent SEC Filing (MT Newswires)
LPRO - Open Lending Corp - Stock Price Chart
TickerLPRO [NASD, RUT]
CompanyOpen Lending Corp
CountryUSA
IndustryCredit Services
Market Cap762.09MEPS (ttm)0.12
P/E53.11EPS this Y22.84%
Forward P/E19.68EPS next Y46.98%
PEG-EPS past 5Y18.40%
P/S6.94EPS next 5Y-13.29%
P/B3.60EPS Q/Q-58.07%
Dividend-Sales Q/Q-19.85%
Insider Own18.41%Inst Own66.89%
Insider Trans-1.35%Inst Trans19.31%
Short Float3.18%EarningsMay 07/a
Analyst Recom1.78Target Price7.67
Avg Volume478.07K52W Range4.57 - 11.73
May-13-24 05:43PM Open Lending Collaborates With Core Specialty Insurance Holding (MT Newswires)
04:30PM Open Lending Partners with Core Specialty Insurance Holdings (Business Wire)
09:54AM Open Lending Corporation (NASDAQ:LPRO) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 12:09PM Canaccord Genuity Adjusts Open Lending Price Target to $6 From $7, Maintains Hold Rating (MT Newswires) +5.29%
12:00PM Needham Adjusts Price Target on Open Lending to $7 From $8, Maintains Buy Rating (MT Newswires)
07:55AM Morgan Stanley Trims Price Target on Open Lending to $6 From $7, Keeps Equalweight Rating (MT Newswires)
07:43AM Q1 2024 Open Lending Corp Earnings Call (Thomson Reuters StreetEvents)
04:13AM Open Lending Corp (LPRO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-07-24 08:59PM LPRO Stock Earnings: Open Lending Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:00PM Open Lending (LPRO) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
CRNC - Cerence Inc - Stock Price Chart
TickerCRNC [NASD, RUT]
CompanyCerence Inc
CountryUSA
IndustrySoftware - Application
Market Cap177.98MEPS (ttm)-6.83
P/E-EPS this Y118.18%
Forward P/E-EPS next Y-119.70%
PEG-EPS past 5Y-
P/S0.51EPS next 5Y15.00%
P/B0.38EPS Q/Q-927.02%
Dividend-Sales Q/Q-0.83%
Insider Own13.89%Inst Own99.02%
Insider Trans-1.73%Inst Trans-4.15%
Short Float18.10%EarningsMay 09/b
Analyst Recom2.75Target Price8.08
Avg Volume936.57K52W Range3.56 - 36.79
May-10-24 03:35PM Cerence Inc (CRNC) Faces Financial Challenges in Q2 2024 Despite Revenue Outperformance (GuruFocus.com) -14.81%
May-09-24 11:58AM CRNC Stock Earnings: Cerence Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) -34.31%
09:30AM Compared to Estimates, Cerence (CRNC) Q2 Earnings: A Look at Key Metrics (Zacks)
08:40AM Cerence (CRNC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM Cerence Announces Second Quarter Fiscal Year 2024 Results (GlobeNewswire)
May-08-24 09:15AM Stay Ahead of the Game With Cerence (CRNC) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
May-06-24 06:00AM Shhh! 3 Secret AI Stocks Flying Below Wall Street's Radar (InvestorPlace)
Apr-25-24 04:30PM Cerence to Announce Fiscal Second Quarter Results on May 9, 2024 (GlobeNewswire) -6.57%
08:00AM Foxtron and Cerence Collaborate to Bring First-of-its-Kind Intuitive Interaction to Foxtron's New Electric Vehicles in Taiwan (GlobeNewswire)
Mar-25-24 09:07AM Cerence (CRNC) Boosts In-Car Experience with CaLLM AI Platform (Zacks)
NVAX - Novavax, Inc. - Stock Price Chart
TickerNVAX [NASD, RUT]
CompanyNovavax, Inc.
CountryUSA
IndustryBiotechnology
Market Cap2.33BEPS (ttm)-3.18
P/E-EPS this Y101.17%
Forward P/E-EPS next Y-968.43%
PEG-EPS past 5Y11.55%
P/S2.34EPS next 5Y37.90%
P/B-EPS Q/Q69.08%
Dividend-Sales Q/Q15.94%
Insider Own4.96%Inst Own56.80%
Insider Trans-0.67%Inst Trans3.20%
Short Float33.68%EarningsMay 10/b
Analyst Recom2.00Target Price18.00
Avg Volume13.15M52W Range3.53 - 15.69
Today 09:45AM Better Buy: Inovio Pharmaceuticals vs. Novavax (Motley Fool) +11.54%
05:50AM 3 Things You Need to Know If You Buy Novavax Today (Motley Fool)
May-21-24 09:01AM Why Novavax (NVAX) Stock Price Appreciated 14% on Monday (Zacks)
06:27AM The $10 Stock Jackpot: 3 Speculative Plays That Could Double Overnight (InvestorPlace)
May-20-24 03:29PM Moderna and Novavax Hope for Early Launch of This Years Covid-19 Shots (Barrons.com) +13.68%
02:31PM Moderna and Novavax Hope for Early Launch of This Years Covid-19 Shots, Despite FDA Delay (Barrons.com)
01:53PM Hedge Fund and Insider Trading News: Ray Dalio, Michael Burry, David Tepper, Elliott Management, Greenlight Capital, Ghisallo Capital Management, Millennium Management, Nextnav Inc (NN), Williams-Sonoma, Inc. (WSM), and More (Insider Monkey)
01:37PM Roaring Kitty's Rally Cry: 3 Meme Stocks to Pounce On Now (InvestorPlace)
07:40AM Novavax Stockholder Shah Capital Withdraws Campaign Against Reelection of Directors (MT Newswires)
07:39AM Shah Capital ends campaign against Novavax board after Sanofi deal (Reuters)
GNLX - Genelux Corp - Stock Price Chart
TickerGNLX [NASD, RUT]
CompanyGenelux Corp
CountryUSA
IndustryBiotechnology
Market Cap147.42MEPS (ttm)-0.97
P/E-EPS this Y20.91%
Forward P/E-EPS next Y-29.34%
PEG-EPS past 5Y-23.84%
P/S14742.00EPS next 5Y-
P/B9.77EPS Q/Q30.73%
Dividend-Sales Q/Q-95.29%
Insider Own25.33%Inst Own22.36%
Insider Trans-4.71%Inst Trans-
Short Float11.52%EarningsMay 09/a
Analyst Recom1.00Target Price26.00
Avg Volume135.82K52W Range3.06 - 40.98
May-09-24 11:53PM GNLX Stock Earnings: Genelux Misses EPS for Q1 2024 (InvestorPlace) +6.07%
04:25PM Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates (GlobeNewswire)
Apr-26-24 09:35AM Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 09:35AM Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-05-24 09:35AM After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX) (Zacks)
Apr-04-24 12:00PM All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy (Zacks)
Apr-02-24 07:52AM GNLX Stock Earnings: Genelux Misses EPS for Q4 2023 (InvestorPlace)
Apr-01-24 07:00AM Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -18.51%
Dec-15-23 03:01PM Insider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX) (GuruFocus.com) -13.23%
Nov-27-23 07:00AM Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer (GlobeNewswire)
BCAN - BYND Cannasoft Enterprises Inc - Stock Price Chart
TickerBCAN [NASD]
CompanyBYND Cannasoft Enterprises Inc
CountryIsrael
IndustrySoftware - Infrastructure
Market Cap4.09MEPS (ttm)-109.32
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S5.69EPS next 5Y-
P/B1.22EPS Q/Q-1725.91%
Dividend-Sales Q/Q-26.33%
Insider Own7.62%Inst Own15.11%
Insider Trans0.00%Inst Trans-
Short Float18.65%Earnings-
Analyst Recom-Target Price-
Avg Volume2.16M52W Range0.65 - 687.80
May-17-24 07:23AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) -23.40%
Apr-19-24 05:00AM 4/20 Cannabis Stocks: Key Players in the Growing Market (News Direct) -13.73%
Apr-05-24 09:00AM The $7 Billion CBD Market in 2023 is Focused on Significant Growth in Personal Care (News Direct)
Apr-03-24 09:02AM A $45 Billion Dollars Market is in the Crosshairs of BYND Cannasoft with a New Series of Concept Smart Fem-Tech Devices (News Direct) -19.84%
Mar-26-24 08:32AM BYND Cannasoft Provides Business Update (News Direct) -20.41%
Mar-22-24 08:31AM BYND Cannasoft Enterprises Inc. Announces 1-for-190 Reverse Stock Split Implemented (News Direct) -31.20%
Mar-18-24 10:30AM Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (ACCESSWIRE) +6.31%
Mar-14-24 12:45PM BYND Cannasoft Enterprises Inc. Announces Closing of $7.0 Million Underwritten Public Offering (News Direct) -11.71%
Mar-12-24 09:00AM BYND Cannasoft Enterprises Inc. Announces Pricing of $7.0 Million Underwritten Public Offering (News Direct) -70.50%
Jan-25-24 09:00AM BYND Cannasoft Entering Production Agreements for its EZ-G Device (GlobeNewswire)
ELDN - Eledon Pharmaceuticals Inc - Stock Price Chart
TickerELDN [NASD]
CompanyEledon Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap70.18MEPS (ttm)-1.49
P/E-EPS this Y31.40%
Forward P/E-EPS next Y44.59%
PEG-EPS past 5Y43.37%
P/S-EPS next 5Y-
P/B0.96EPS Q/Q54.47%
Dividend-Sales Q/Q-
Insider Own5.56%Inst Own36.04%
Insider Trans0.00%Inst Trans-1.35%
Short Float0.15%EarningsMay 09/b
Analyst Recom1.00Target Price14.00
Avg Volume182.16K52W Range1.07 - 3.35
May-14-24 12:00PM Eledon Pharmaceuticals (ELDN) Moves to Buy: Rationale Behind the Upgrade (Zacks) +6.85%
May-09-24 01:54PM ELDN Stock Earnings: Eledon Pharma Beats EPS for Q1 2024 (InvestorPlace)
07:30AM Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results (GlobeNewswire)
07:00AM Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress (GlobeNewswire)
May-07-24 07:05AM Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection (GlobeNewswire) -7.38%
07:00AM Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement (GlobeNewswire)
Mar-28-24 04:01PM Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results (GlobeNewswire)
Mar-25-24 04:56PM Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection (GlobeNewswire)
Mar-21-24 10:31AM Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human (GlobeNewswire) +11.24%
Feb-13-24 07:01PM Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
SABS - SAB Biotherapeutics Inc - Stock Price Chart
TickerSABS [NASD]
CompanySAB Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap26.07MEPS (ttm)-5.51
P/E-EPS this Y47.77%
Forward P/E-EPS next Y-9.27%
PEG-EPS past 5Y-
P/S10.03EPS next 5Y-
P/B0.49EPS Q/Q-272.72%
Dividend-Sales Q/Q62.55%
Insider Own18.89%Inst Own36.20%
Insider Trans1.03%Inst Trans40.11%
Short Float0.30%EarningsMay 20/b
Analyst Recom1.00Target Price15.50
Avg Volume17.74K52W Range2.50 - 10.50
May-21-24 09:53AM SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024 (InvestorPlace) -15.65%
07:15AM FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics (GlobeNewswire)
May-20-24 05:45PM SAB Biotherapeutics Announces Q1 2024 Financial Results and Provides Company Updates (GlobeNewswire)
May-06-24 07:15AM SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors (GlobeNewswire)
Apr-16-24 07:15AM SAB Biotherapeutics Provides SAB-142 Trial Update (GlobeNewswire) +5.86%
Apr-08-24 07:15AM SAB Biotherapeutics to Present at INNODIA Annual Meeting (GlobeNewswire)
Apr-04-24 07:15AM SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-24 07:15AM SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results (GlobeNewswire)
Mar-25-24 10:15AM SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment (GlobeNewswire) -12.91%
Feb-23-24 08:00AM SAB Biotherapeutics to Present at the BIO CEO & Investor Conference (GlobeNewswire)
123456789101112⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.